Machine Perfusion-Leaving Its Mark on Liver Transplantation
- PMID: 33492117
- DOI: 10.1097/TP.0000000000003462
Machine Perfusion-Leaving Its Mark on Liver Transplantation
Conflict of interest statement
A.J.B. is part owner of a patent on the circuit used by the OrganOx metra device. The remaining authors of this manuscript have no conflicts of interest to disclose.
References
-
- NHS: Blood and Transplant. Annual Report on Liver Transplantation: Report for 2018/2019. 2019. Available at: https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/16782/nhsbt-l... . Accessed August 1, 2020.
-
- Taylor R, Allen E, Richards JA, et al.; Liver Advisory Group to NHS Blood and Transplant. Survival advantage for patients accepting the offer of a circulatory death liver transplant. J Hepatol. 2019; 70:855–865.
-
- Watson CJE, Kosmoliaptsis V, Pley C, et al. Observations on the ex situ perfusion of livers for transplantation. Am J Transplant. 2018; 18:2005–2020.
-
- Pareja E, Cortes M, Hervás D, et al. A score model for the continuous grading of early allograft dysfunction severity. Liver Transpl. 2015; 21:38–46.
-
- Richards JA, Sherif AE, Butler AJ, et al. Model for early allograft function is predictive of early graft loss in donation after circulatory death liver transplantation. Clin Transplant. 2020; 34:e13982.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
